Aquestive Therapeutics appoints Rich Daly to board effective Oct 14, 2026

The board will have eight directors after the appointment takes effect on Oct. 14, 2026. Daly has more than 30 years of biopharma leadership, including roles at AstraZeneca and Takeda.